498 patients tested, 2,000 employees WFH
Cynthia Hundorfean is president and CEO of Allegheny Health Network, a Highmark Health health system in western Pennsylvania, and a member of the Managed Healthcare Executive editorial board. We emailed her some questions about how her health system is coping with the COVID-19 pandemic.
Has Allegheny Health Network had any COVID-19 cases? Yes. We are currently treating 2 COVID-19 inpatients.
Do your facilities have access to COVID-19 testing? We are currently utilizing commercial labs for testing and have tested 498 patients to date. Most of this testing continues to be done in the outpatient setting and at our emergency departments.
Have you canceled elective surgeries and other nonurgent sorts of care? If so, have you taken steps to reduce staffing levels in some way?
Yes, we have postponed all elective surgeries and nonessential clinical care. As a result, we have been moving staff into cross-functional roles as needed.
How many people are working from home and in what kind of jobs? AHN currently has more than 2,000 employees deployed to work from home across our finance, revenue cycle, analytics, clinical access, and administrative support teams. We continue to explore solutions to allow for additional teams to work remotely.
As a healthcare leader, what has been the hardest part of dealing COVID-19. Have there been any gratifying moments? The hardest part is constantly worrying about our physicians, nurses, and everyone else in our hospitals that will be routinely exposed to the virus. They will continue to be tested by this scenario, and I hope they know how much we honor them for the work they have been and are about to do.
Gratifying moments-the clock is meaningless now. There’s no beginning or end to our workday. It’s everyone working together with the same goal. It should be like this all of the time.
Unrealistic Portrayals of Cardiac Arrest in Contemporary Film | ACC 2025
March 31st 2025Cardiac arrests in contemporary film are largely inaccurate when it comes to survival rate and etiology, according to a poster presented today at the American College of Cardiology conference held March 29 to 31 in Chicago.
Read More
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
Winrevair Reduced Risk of Morbidity and Mortality by 76% in PAH | ACC 2025
March 31st 2025In the ZENITH trial, Winrevair was evaluated based on a composite endpoint of all-cause death, lung transplantation or disease-related hospitalization for patients with pulmonary arterial hypertension.
Read More
Clopidogrel Beat Aspirin in Preventing Heart Attacks After PCI | ACC 2025
March 31st 2025Clopidogrel monotherapy may be an alternative to aspirin for prevention of cardiac events in high-risk patients after percutaneous coronary intervention, according to a new study presented at ACC 2025.
Read More